Technology

Since each consumer has unique preferences and online habits, marketers should leverage a variety of channels to capture a high volume of targeted consumer profile data, without jeapordizing the quality of their lists.

At least five of the world's top pharma companies have specified, tested, or deployed large-scale Wi-Fi programs.

Marketers can leverage thetransparency of the Web by listening in and mining thousands of conversations about their clients' brands.

Seniors represent an ideal, captive audience. Because they tend to have more leisure time, they are often willing to take the time to read in-depth information.

The most important result for pharma firms of the changing sales structure is a reduction in the amount of training resources that are available to them.

When investigating a health condition, most consumers search for information by inputting their symptoms. Offering symptoms-related information on your site could help improve its ranking.

When you have a workable technology, the question becomes ‘To what do you apply this technology?’ and ‘Where do you spend your time?’ We really believed we would be most successful by spending a lot of time figuring out which drugs to work on and then working assiduously on those few products with huge potential.

Because mobile devices are a convenient source for breaking headlines and other news, many physicians have adopted mobile news services to stay abreast of specialty journals and clinical news.

The ideal healthcare package, in addition to reflecting the quality of the product it contains, fortifies brand equity and differentiates the product in the marketplace.

Digital forms of image transmission, archiving, and education with the virtual microscope will revolutionize pathology.

The issue of pedigree requirements is emerging at the state level-and figuring out to what extent that will push back to the manufacturers.

In the healthcare and pharma industries, where lives are at stake and skepticism proliferates, consumers are even more apt to turn to peers for trusted information and advice about medical treatments.

Imagine drugs that can detect one particular compound in a patient's body and respond to it by releasing a drug. They're not that far away.

RSS has the power to change how users consume Web-based content, giving them control of their information and increased privacy.

Procter & Gamble Pharmaceuticals discovered that a network resulting from even a modest integration offered benefits that exceeded the sum of its parts.

Garry Barnes says he joined the pharma industry for job security-but don't believe him. During the last 25 years, Barnes has worked for four pharma companies and built five sales forces in therapeutic areas ranging from contraception to organ transplantation.

For pharma companies large and small, one of the most pressing challenges of the next few years will be to understand compliance at a much deeper level, to obtain the tools to make it possible.

Without common reporting standards in place, researchers have little incentive to share data with scientists elsewhere in the company. When researchers don't sharedata on a regular basis, they can begin to feel proprietary about their work-and even less inclined to disclose their results.

Pilot projects involving RFID technology are appearing at some major pharma companies. But uptake of RFID-based solutions remains limited due to concerns about accuracy, reliability, and ROI.

Pharma companies believe that they can compete in an e-prescribing environment if information systems permit full disclosure and allow doctors to create bookmarks that link easily to information they want.

Without common reporting standards in place, researchers have little incentive to share data with scientists elsewhere in the company. When researchers don't sharedata on a regular basis, they can begin to feel proprietary about their work-and even less inclined to disclose their results.

The race among health information portals may result in better content offerings for consumers. Advertisers that move first have the opportunity to buy out targeted inventory at a good rate.

Pharma companies are committed to using electronic data capture in clinical trials. Technology adoption will continue to grow, as FDA and consumers want faster safety data.

Electronic patient-reported outcomes tools let trial sponsors enforce recording deadlines and compliance. They help keep subjects honest.

CMS envisions studies to show which drugs keep patients out of hospitals or how certain treatments can reduce side effects. Such analysis would support decisions on best practices in using medications.

Even though data can single out physicians with high marketing upsides, most pharma companies are doing without such high-value data.

The future of US healthcare is being created today in Medicare's demonstration programs. But how you respond to them depends a lot on what kind of company you are.

In a non-human primate study, high doses of Neumune resulted in 90 percent survival against a lethal level of radiation.

Having an efficient, integrated call center can be a matter of life or death. Imagine a pharma company not knowing for several weeks that the active ingredient in a life-saving drug was left out of the final product? How would they learn of the error if the quality control at the manufacturing plant failed to identify the problem? Most likely, the next opportunity for identifying such a crisis is through the call center-the key interface between healthcare professionals, consumers, and the company. However, it's not enough to log complaints about a product's efficacy. Once documented, complaints need to be routed to the right department, evaluated, and consolidated. If a streamlined process isn't in place, weeks could pass without anyone ever taking any action-even as adverse event records pile up.

The use of a CUI leads development efforts to explre the most valuable region of treatment - not necessarily the the most efficacious.